Literature DB >> 17126094

Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis.

Tomasz J Kuzniar1, Matthew G Blum, Kamilla Kasibowska-Kuzniar, Gökhan M Mutlu.   

Abstract

BACKGROUND: Acute lung injury (ALI) is a life-threatening complication of talc pleurodesis. This study defines characteristics that predispose patients to ALI and severe hypoxemia in patients after video-assisted thoracoscopic surgery (VATS) talc pleurodesis.
METHODS: Charts of patients who underwent talc pleurodesis at Northwestern Memorial Hospital between January 1, 1997 and December 31, 2003 were retrospectively reviewed. We sought variables associated with the development of postoperative ALI or severe hypoxemia, defined as an increase in fraction of the inspired oxygen by more than 0.15 within 24 hours after the surgery. The analysis included 84 patients (58 women, 26 men) who underwent VATS talc pleurodesis for malignant (n = 74) or benign (n = 10) indications.
RESULTS: ALI developed in 5 patients (5.9%), severe hypoxemia developed in 25 (29.8%), and 54 (64.3%) did not have postoperative complications. In multivariate analysis, the presence of peripheral edema before pleurodesis (p = 0.005), any preoperative requirement for supplemental oxygen (p = 0.032), and chemotherapy within 14 days before pleurodesis (p = 0.04) were identified as predictors of ALI or severe postoperative hypoxemia.
CONCLUSIONS: Oxygen supplementation, recent chemotherapy, and presence of peripheral edema were independent predictors of a combined outcome of ALI or severe hypoxemia after VATS talc pleurodesis. Patients with these characteristics might be at risk for adverse outcomes of talc pleurodesis and should be considered for alternative therapy for their effusions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126094     DOI: 10.1016/j.athoracsur.2006.06.040

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition.

Authors:  Joseph E Levitt; Michael A Matthay
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

2.  Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis.

Authors:  Valliappan Muthu; Sahajal Dhooria; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashutosh N Aggarwal; Ritesh Agarwal
Journal:  Support Care Cancer       Date:  2021-01-30       Impact factor: 3.603

3.  Adverse events after pleurodesis in patients with malignant pleural effusion.

Authors:  Ricardo Mingarini Terra; Priscila Berenice da Costa; Alberto Jorge Monteiro Dela Vega; Paulo Manuel Pêgo-Fernandes
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

4.  Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion.

Authors:  Norihito Yokoe; Eisuke Katsuda; Kenshi Kosaka; Rie Hamanaka; Ayako Matsubara; Masaki Nishimura; Hiroyuki Tanaka; Nobuhiro Asai; Ayumu Takahashi; Toshiki Kawamura; Tsuneo Ishiguchi; Etsuro Yamaguchi; Akihito Kubo
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

5.  Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion.

Authors:  Dong Woog Yoon; Jong Ho Cho; Yong Soo Choi; Jhingook Kim; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Thorac Cancer       Date:  2016-05-05       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.